Moreover, considering that anxiety plays an important fact in migraine risk, detecting anxiety symptoms and implementing pharmacological and not treatments targeting Nrf-2/NF-κB pathway could improve headache control and patient’s quality of life. The gene discussed is NFE2L2; the disease is Anxiety.